Ladenburg Thalmann initiated coverage of Liquidia (NASDAQ:LQDA) with a “buy” rating and $15 price target. The stock closed at $5.03 on July 21. Liquidia is a commercial-stage biotechnology company currently focused on...
BTIG initiated coverage of Liquidia (NASDAQ:LQDA) with a “buy” rating and $14 price target. The stock closed at $4.07 on May 27. Analyst Julian Harrison writes that Liquidia has brought its lead candidate, YUTREPIA, to...
H.C. Wainwright initiated coverage of Liquidia Technologies (NASDAQ:LQDA) with a “buy” rating and price target of $6. The stock closed at $2.92 on Dec. 3. Liquidia is focused on applying its particle engineering PRINT...